ArticleThe journal of allergy and clinical immunology. Global2026
Skin barrier function in children with eosinophilic esophagitis.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Eosinophilic esophagitis (EoE) is associated with epithelial barrier dysfunction of the esophagus. Studies suggest that the skin lipidomic profile is altered in EoE; therefore, we hypothesized that skin barrier function would be compromised in subjects with EoE. Objective: We aimed to evaluate skin barrier function in subjects with EoE by assessing transepidermal water loss (TEWL). Methods: We performed a single-center, case-control study of pediatric subjects with known EoE and controls without EoE. The subjects with EoE met consensus criteria for diagnosis. Patients receiving systemic biologic medications or prescription topical corticosteroids were excluded. A majority of the subjects with EoE underwent a concurrent esophageal string test or had a recent endoscopy near the time of TEWL assessment. In addition to comparing subjects with EoE and controls without EoE, we compared TEWL according to EoE disease activity. Results: The subjects with EoE (n = 25) were older than the controls without EoE (n = 24) but similar from the standpoint of other demographic features. The controls were primarily atopic (79.2%). Rate of TEWL was comparable in the subjects with EoE and the controls (median =15.1 [interquartile range = 4.95] g/m Conclusions: Subjects with EoE did not have marked skin barrier dysfunction relative to the controls without EoE and TEWL did not vary according to disease activity. These findings suggest that the utility of TEWL as a biomarker of EoE is limited. Larger studies with defined atopic and nonatopic controls are needed to detect small to moderate differences in skin barrier function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.